Filter
890
Text search:
adverse
drug
reactions
Featured
Recommendations
116
New Publications
260
Language
Document type
No document type
585
Guidelines
144
Studies & Reports
79
Manuals
42
Strategic & Response Plan
13
Fact sheets
11
Training Material
9
Situation Updates
3
Brochures
2
Resource Platforms
1
Infographics
1
Countries / Regions
India
68
Kenya
28
South Africa
27
Ethiopia
26
Tanzania
22
Western and Central Europe
21
Uganda
19
Nigeria
17
Zambia
17
Global
17
Malawi
16
Nepal
15
Ghana
14
Philippines
10
Cambodia
10
Bangladesh
10
Latin America and the Carribbean
10
Eastern Europe
10
Sierra Leone
9
Zimbabwe
9
Liberia
8
Namibia
8
Myanmar / Burma
8
Africa
8
USA
6
Rwanda
6
Botswana
6
Eswatini/ Swaziland
5
South–East Asia Region
5
South Sudan
3
Germany
3
Syria
3
Indonesia
3
Brazil
3
Ukraine
3
Western Pacific Region
3
Congo, Democratic Republic of
2
Haiti
2
Thailand
2
Argentina
2
Colombia
2
Bolivia
2
Lesotho
2
Sri Lanka
2
Asia
2
Timor Leste/ East Timor
2
Russia
2
Cameroon
1
Iraq
1
Lebanon
1
Gambia
1
China
1
Ireland
1
Mozambique
1
Benin
1
Angola
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Solomon Islands
1
Bhutan
1
North Korea
1
Laos
1
Australia
1
Georgia
1
Vietnam
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
351
Clinical Guidelines
136
Public Health
43
Women & Child Health
26
Capacity Building
15
Key Resources
12
Pharmacy & Technologies
11
Toolboxes
TB
130
Mental Health
78
HIV
69
Pharmacy
66
COVID-19
35
NTDs
34
AMR
27
Ebola
18
Caregiver
17
NCDs
14
Rapid Response
12
Refugee
10
Polio
8
Conflict
8
Specific Hazards
5
Cholera
4
Natural Hazards
4
Planetary Health
4
Disability
3
Zika
3
Global Health Education
3
Health Financing Toolbox
1
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
A survival guide for clinicans.
3rd edition.
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone refere
...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of ...
The term "Programmatic Management of ...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International
...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential com
...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is
...
2nd edition
World Drug Report 2018
-3-